Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region

• Published in: Liver international 2023-10, Vol.43 (10), p.2062-2077
• Main Authors: Waked, Imam, Alsammany, Sherif, Tirmazy, Sayed Hammad, Rasul, Kakil, Bani-Issa, Jafar, Abdel-Razek, Wael, Omar, Ashraf, Shafik, Amr, Eid, Salem, Abdelaal, Amr, Hosni, Ahmed, Esmat, Gamal
• Format: Article
• Language: English
• Subjects: Biomarkers; Fatty liver; Health services; Hepatitis C; Hepatocellular carcinoma; Liver; Liver cancer; Liver diseases; Patients; Risk factors; Standardization; Surveillance systems; System effectiveness
• ISSN: 1478-3223; 1478-3231
• DOI: 10.1111/liv.15685

Hepatocellular carcinoma (HCC) is a growing health concern projected to cross over a million cases worldwide by 2025. HCC presents a significant burden of disease in Middle East and North African (MENA) countries due to a high prevalence of risk factors such as hepatitis C and B infections and rising incidence of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. In August 2022, an advisory meeting consisting of experts from 5 MENA countries was convened in an attempt to provide consensus recommendations on HCC screening, early diagnosis, current treatment modalities and unmet medical needs in the region. Data were collected from a pre-meeting survey questionnaire and responses analysed and presented during the advisory meeting. This review summarizes the evidence discussed at the meeting and provides expert recommendations on the management of HCC. The 2022 update of Barcelona clinic liver cancer (BCLC) staging and treatment strategy and its implementation in the MENA region was extensively discussed. A key consensus of the expert panel was that multidisciplinary care is crucial to effective patient management that results in better clinical outcomes and overall survival of the patient. The panel recommended the use of predictive and early response biomarkers to guide clinicians in arriving at more effective therapeutic decisions. The experts also emphasized the role of robust screening/surveillance systems, population-based registries, effective referral pathways and standardization of guidelines to ensure the successful management of HCC in the region.